TE_11709

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family L1HS_5end
TE superfamily L1
TE class LINE
Gene -, ENSG00000251361
Class Chimeric, Intergenic
Coding Non-coding
Tumor-specific score 176.95
Counts of samples TCGA_tumor:470; TCGA_normal:2; GTEx:0
TSS chr5(-):93213276



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_11709.11 - Intergenic Non-coding Non-coding chr5(-):93075730,93075750,93090366,93090437,93149826,93149906,93191090,93191166,93213128,93213277
teRNA_11709.12 - Intergenic Non-coding Non-coding chr5(-):93149886,93149906,93191090,93191166,93213128,93213277
teRNA_11709.13 - Intergenic Non-coding Non-coding chr5(-):93135933,93135953,93149826,93149906,93191090,93191166,93213128,93213277
teRNA_11709.14 - Intergenic Non-coding Non-coding chr5(-):93135933,93135953,93149826,93149906,93213128,93213277
teRNA_11709.15 ENSG00000251361 Chimeric Non-coding Non-coding chr5(-):93020116,93020136,93051670,93051776,93075658,93075750,93090366,93090437,93149826,93149906,93213128,93213277
teRNA_11709.16 - Intergenic Non-coding Non-coding chr5(-):93110566,93110586,93135785,93135953,93149826,93149906,93213128,93213277
teRNA_11709.17 ENSG00000251361 Chimeric Non-coding Non-coding chr5(-):93020116,93020136,93051670,93051776,93075658,93075750,93090366,93090437,93135785,93135953,93149826,93149906,93213128,93213277
teRNA_11709.18 ENSG00000251361 Chimeric Non-coding Non-coding chr5(-):93020116,93020136,93051670,93051776,93068626,93068667,93075658,93075750,93090366,93090437,93135785,93135953,93149826,93149906,93213128,93213277
teRNA_11709.19 - Intergenic Non-coding Non-coding chr5(-):93075730,93075750,93090366,93090437,93135785,93135953,93149826,93149906,93213128,93213277
teRNA_11709.20 - Intergenic Non-coding Non-coding chr5(-):93075730,93075750,93149826,93149906,93213128,93213277


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).